In summary, scopolamine produced severe deficits in the performance of mice in the Morris water maze test, along with signs of memory impairments, including changed AChE activity and altered PI3K and ERK/CREB/BDNF pathways in the hippocampus. Here, BDNF is linked to memory impairment.